Study: FDA approved five drugs to treat rare diseases using RWE in 2020-2022
Regulatory NewsJoanne S. Eglovitch
CDERPharmaceuticalsRegulatory Intelligence/PolicyRWE/RWDUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsJoanne S. EglovitchCDERPharmaceuticalsRegulatory Intelligence/PolicyRWE/RWDUnited StatesUS Food and Drug Administration (FDA)